Psoriasis exacerbation associated with bupropion-induced exanthema

Forskningsoutput: Tidskriftsbidrag › Brev › Vetenskaplig

Originalspråk	engelska
Tidskrift	Annales de Dermatologie et de Venereologie
Volym	150
Nummer	1
Sidor (från-till)	73-75
Antal sidor	3
ISSN	0151-9638
DOI	https://doi.org/10.1016/j.annder.2022.09.003
Status	Publicerad - mars 2023
MoE-publikationstyp	B1 Artikel i en vetenskaplig tidskrift

Vetenskapsgrenar

@article{f6af6054a7f940199c3e2a1b233e7d45,

title = "Psoriasis exacerbation associated with bupropion-induced exanthema",

keywords = "Bupropion, Drug-induced exanthema, Psoriasis, Smoking, Tobacco, 3121 General medicine, internal medicine and other clinical medicine",

author = "N. Kluger",

year = "2023",

month = mar,

doi = "10.1016/j.annder.2022.09.003",

language = "English",

volume = "150",

pages = "73--75",

journal = "Annales de Dermatologie et de Venereologie",

issn = "0151-9638",

publisher = "Elsevier Masson s.r.l.",

number = "1",

}

TY - JOUR

T1 - Psoriasis exacerbation associated with bupropion-induced exanthema

AU - Kluger, N.

PY - 2023/3

Y1 - 2023/3

KW - Bupropion

KW - Drug-induced exanthema

KW - Psoriasis

KW - Smoking

KW - Tobacco

KW - 3121 General medicine, internal medicine and other clinical medicine

U2 - 10.1016/j.annder.2022.09.003

DO - 10.1016/j.annder.2022.09.003

M3 - Letter

C2 - 36424302

SN - 0151-9638

VL - 150

SP - 73

EP - 75

JO - Annales de Dermatologie et de Venereologie

JF - Annales de Dermatologie et de Venereologie

IS - 1

ER -